Who is sponsoring NCT05823051?

NCT05823051 is sponsored by Dilara Aydin Tozlu.

What drugs are being tested in NCT05823051?

Interventions in NCT05823051: VASIDS-TP and Counseling Practice.

What condition does NCT05823051 study?

NCT05823051 studies Sudden Infant Death.

Is NCT05823051 still recruiting?

NCT05823051 is currently status unknown. Last updated 21 April 2023.

Last reviewed 2023-04-21 · How we verify

NCT05823051

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Video-Assisted Sudden Infant Death Syndrome Prevention Training Program and Counseling Practice on Mothers' Knowledge Level and Self-efficacy: Randomized Controlled Study

Status unknown NA Last updated 21 April 2023

What this trial tests

NA trial testing VASIDS-TP and Counseling Practice in Sudden Infant Death in 80 participants. Status unknown.

Timeline

1 July 2023

Primary endpoint
15 October 2023

15 November 2023

Quick facts

Lead sponsor	Dilara Aydin Tozlu
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	80
Start date	1 July 2023
Primary completion	15 October 2023
Estimated completion	15 November 2023

Drugs / interventions tested

VASIDS-TP and Counseling Practice

Conditions studied

Sudden Infant Death — all drugs for Sudden Infant Death →

Sponsor

Dilara Aydin Tozlu

Who can join

Eligibility, female only, with Sudden Infant Death. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Sudden Infant Death Syndrome (SIDS) is one of the leading causes of infant mortality in the postneonatal period, but it can be prevented and its incidence can be reduced by creating a safe sleep environment with modifiable risk factors. It is known that parents, infant care providers and healthcare professionals do not have sufficient knowledge about SIDS and safe sleep, and especially mothers exhibit many risky behaviors in terms of SIDS, such as using the wrong sleeping positions while putting their babies to sleep. Therefore, it is of critical importance to inform and raise awareness of parents on the issues of SIDS and safe sleep, which remain important today, on the premise of promoting public health.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Sudden Infant Death

Currently open trials in the same condition.

NCT06618586 — Get Social Media and Risk-Reduction Training · NA · recruiting
NCT05503771 — Improving Pediatrician Counseling About Infant Safe Sleep Using the Electronic Medical Record · NA · recruiting
NCT03775954 — Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05823051 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dilara Aydin Tozlu
Last refreshed: 21 April 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05823051.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing